MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

BGLC — BioNexus Gene Lab Corp Common stock

Nasdaq

BioNexus Gene Lab Corp Common stock

CompareBack to Screener
$1.27
+0.07(+5.83%)
O
1.25
H
1.28
L
1.25
V
2.53K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About BGLC

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

IndustrySERVICES-MEDICAL LABORATORIES
SectorNot available
IPO DateMar 11, 2020
Employees1
Stock ExchangeNasdaq
Ticker SymbolBGLC

Key Financial Statistics

Market Cap$4.08M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$1.07 - $5.89
52-Week Avg Volume67.0K
VWAP$1.26
Transactions56
Total Recorded Bars1,436 days